tiprankstipranks

Syntara Limited Announces Director’s Interest Change

Story Highlights
  • Syntara Limited reported a change in director’s interest involving Waradana Malitha Hashan De Silva.
  • The KP Rx Healthcare Trust acquired 9,753,442 shares, affecting Syntara’s shareholding structure.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Syntara Limited Announces Director’s Interest Change

Pharmaxis Ltd ( (AU:SNT) ) has shared an update.

Syntara Limited has announced a change in the director’s interest notice, specifically involving Waradana Malitha Hashan De Silva, who is a managing partner of the manager of the KP Rx Healthcare Trust. The trust, through AMAL Security Services Pty Ltd, acquired 9,753,442 ordinary shares at $0.06 per share, increasing the total shares held indirectly by the trust to 63,324,871. This acquisition was part of a placement of ordinary shares approved by shareholders, potentially impacting the company’s market positioning by increasing its shareholding structure.

More about Pharmaxis Ltd

YTD Price Performance: -7.50%

Average Trading Volume: 3,674,631

Technical Sentiment Consensus Rating: Sell

Current Market Cap: A$118.5M

Learn more about SNT stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App